Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients
NCT00280917
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
254
Enrollment
INDUSTRY
Sponsor class
Conditions
Rheumatoid Arthritis
Interventions
DRUG:
CF101
Sponsor
Can-Fite BioPharma